Chesterfield, MO, United States of America

Justin Abate

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Justin Abate. Retrieved from https://idiyas.com/inventor/justin-abate

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Justin Abate: Innovator in Anti-CTLA-4 Antibody Compositions

Introduction

Justin Abate is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody compositions that have the potential to treat various diseases.

Latest Patents

Justin holds a patent for "Anti-CTLA-4 antibody compositions." This invention provides novel compositions of anti-CTLA-4 antibodies that include a chelating agent. The patent also outlines methods for treating diseases and conditions using these innovative compositions, particularly focusing on various neoplasia conditions. He has 1 patent to his name.

Career Highlights

Justin Abate is currently employed at Pfizer Corporation, a leading global biopharmaceutical company. His work at Pfizer involves research and development in the field of immunotherapy, where he applies his expertise in antibody technology to create effective treatments.

Collaborations

Throughout his career, Justin has collaborated with talented professionals such as Kevin Muthurania and Sandeep Nema. These collaborations have enhanced his research efforts and contributed to the advancement of innovative therapies.

Conclusion

Justin Abate is a prominent figure in the field of biotechnology, with a focus on anti-CTLA-4 antibody compositions. His work at Pfizer Corporation and his innovative patent highlight his commitment to advancing medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…